» Articles » PMID: 38485785

One-pot Method for Preparing DNA, RNA, and Protein for Multiomics Analysis

Overview
Journal Commun Biol
Specialty Biology
Date 2024 Mar 15
PMID 38485785
Authors
Affiliations
Soon will be listed here.
Abstract

Typical multiomics studies employ separate methods for DNA, RNA, and protein sample preparation, which is labor intensive, costly, and prone to sampling bias. We describe a method for preparing high-quality, sequencing-ready DNA and RNA, and either intact proteins or mass-spectrometry-ready peptides for whole proteome analysis from a single sample. This method utilizes a reversible protein tagging scheme to covalently link all proteins in a lysate to a bead-based matrix and nucleic acid precipitation and selective solubilization to yield separate pools of protein and nucleic acids. We demonstrate the utility of this method to compare the genomes, transcriptomes, and proteomes of four triple-negative breast cancer cell lines with different degrees of malignancy. These data show the involvement of both RNA and associated proteins, and protein-only dependent pathways that distinguish these cell lines. We also demonstrate the utility of this multiomics workflow for tissue analysis using mouse brain, liver, and lung tissue.

References
1.
Hu C, Jia W . Multi-omics profiling: the way towards precision medicine in metabolic diseases. J Mol Cell Biol. 2021; . PMC: 8697344. DOI: 10.1093/jmcb/mjab051. View

2.
Olivier M, Asmis R, Hawkins G, Howard T, Cox L . The Need for Multi-Omics Biomarker Signatures in Precision Medicine. Int J Mol Sci. 2019; 20(19). PMC: 6801754. DOI: 10.3390/ijms20194781. View

3.
Garcia M, Juhos S, Larsson M, Olason P, Martin M, Eisfeldt J . Sarek: A portable workflow for whole-genome sequencing analysis of germline and somatic variants. F1000Res. 2020; 9:63. PMC: 7111497. DOI: 10.12688/f1000research.16665.2. View

4.
Anurag M, Jaehnig E, Krug K, Lei J, Bergstrom E, Kim B . Proteogenomic Markers of Chemotherapy Resistance and Response in Triple-Negative Breast Cancer. Cancer Discov. 2022; 12(11):2586-2605. PMC: 9627136. DOI: 10.1158/2159-8290.CD-22-0200. View

5.
Fan Y, Kao C, Yang F, Wang F, Yin G, Wang Y . Integrated Multi-Omics Analysis Model to Identify Biomarkers Associated With Prognosis of Breast Cancer. Front Oncol. 2022; 12:899900. PMC: 9232398. DOI: 10.3389/fonc.2022.899900. View